Sectors
Health, Analytics, Wellness, Education
Headquarters
New York, NY, USA
CEO
Virgílio Bento
Sword Health shares, as of Apr 21, 2025, are valued at a price per share implying an approximate 27.99% premium to their to their last round.Sword Health shares, as of Apr 21, 2025, are valued at a price per share implying an approximate 27.99% premium to their to their last round. Sword Health shares, as of April 21, 2025, are valued at a price per share implying an approximate +131.7% relative to the most recent significant secondary market activity in September 2024, according to PM Insights' market data. PM Insights uses a market-driven derived price methodology to determine Sword Health's valuation when recent secondary market transactions are limited or unavailable, as is currently the case for Sword Health.
Register today to view the full report, with more in-depth details and analytics
Series E Valuation
Latest funding round
$3.0B
XXXXX
2024-06-04
XX-XX-XXXX
PM Insights Implied Valuation
$3.84B
2025-04-21
AV Implied Valuation
XXXXX
XX-XX-XXXX
Change since Last Round
+27.99%
2024-06-04 ➞ 2025-04-21
Change since Last Round
XXXXX
XX-XX-XXXX
Secondary Activity
XXXXX
Business Partnerships
Targeted Impact
Who Will Benefit?
What Comes Next?
No items found.
.png)
Sword Health shares, as of April 21, 2025, are valued at a price per share implying an approximate +131.7% relative to the most recent significant secondary market activity in September 2024, according to PM Insights' market data. PM Insights uses a market-driven derived price methodology to determine Sword Health's valuation when recent secondary market transactions are limited or unavailable, as is currently the case for Sword Health.
Sword Health's mutual fund disclosures indicate a three-month moving average fund price per share of $25.1 as of December 30, 2024, according to PM Insights' market data.
PM Insights tracks detailed primary funding rounds and verifies cap table directly from original filings for Sword Health. Sword Health raised $30.0M in its Series E on June 4, 2024, with a price per share reflecting a post-money valuation of $3.0B, according to PM Insights' market data.
No items found.
No items found.
Ready to see it in action?
Schedule a demo with one of our experts
